<DOC>
	<DOCNO>NCT02249871</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial investigate influence omeprazole pharmacokinetics ( exposure trial drug body ) oral semaglutide healthy subject .</brief_summary>
	<brief_title>Investigating Influence Omeprazole Pharmacokinetics Oral Semaglutide Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Male female age 1875 year ( inclusive ) time sign informed consent Body mass index 18.529.9 kg/m^2 ( inclusive ) A good general health base medical history , physical examination , result vital sign , electrocardiogram laboratory safety test perform screen visit , judge investigator Female pregnant , breastfeed intend become pregnant childbearing potential use adequate contraceptive method . Female child bear potential must use effective method birth control duration trial 5 week follow last dose . Only highly effective method birth control accept ( i.e. , one result less 1 % per year failure rate use consistently correctly , implant , injectables , combine oral contraceptive , intrauterine device ) History Crohn 's disease , ulcerative colitis , inflammatory bowel disease Hypertension ( define sit systolic blood pressure equal 140 mmHg and/or diastolic blood pressure equal 90 mmHg ) . If whitecoat hypertension suspect screen visit repeat measurement allow Any blood draw excess 25 mL past month , donation blood plasma excess 400 mL within 3 month precede screening</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>